Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy
NCT07071688
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
338
Enrollment
OTHER
Sponsor class
Conditions
Tumor
Radiotherapy
Biomarker
Sponsor
Nanfang Hospital, Southern Medical University